DCAF13 Antibody (YA6537)

(Synonyms: DCA13_HUMAN antibody; DCAF13 antibody; DDB1 and CUL4 associated factor 13 antibody; DDB1- and CUL4-associated factor 13 antibody; DKFZP564O0463 antibody; GM83 antibody; HSPC064 antibody; MGC126859 antibody; MGC138247 antibody; WD repeat and SOF domain-containing protein 1 antibody; DCA13_HUMAN antibody; DCAF13 antibody; DDB1 and CUL4 associated factor 13 antibody; DDB1- and CUL4-associated factor 13 antibody; DKFZP564O0463 antibody; GM83 antibody; HSPC064 antibody; MGC126859 antibody; MGC138247 antibody; WD repeat and SOF domain-containing protein 1 antibody; WD repeats and SOF1 domain containing antibody; WDSOF1 antibody; )
Customer Review

Based on 1 Customer Validation

DCAF13 Antibody (YA6537) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to DCAF13.

For research use only. We do not sell to patients.
  • Host:

    Rabbit

  • Isotype:

    IgG

  • Application:

    WB, IHC-P, IP

  • Reactivity :

    Human, Mouse, Rat

  • Formulation:

    Supplied in 1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.

  • Conjugation:
    Non-conjugated

Applications

Application
WB Info
WB: Western Blot
IHC-P Info
IHC-P: Immunohistochemistry-Paraffin
IP Info
IP: Immunoprecipitation
Dilution Ratio 1:1000 1:200 1-2μg/sample

Product Details

Description

DCAF13 Antibody (YA6537) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to DCAF13.

  • Host Rabbit
  • Clonality Recombinant,Monoclonal
  • Species Reactivity
    Human, Mouse, Rat
  • Observed Molecular Weight
    Observed band size: 49 kDa Info
    Note: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
  • Calculated Molecular Weight Predicted band size: 51 kDa
Immunogen

Recombinant protein within Human DCAF13 aa 1-100 / 445.

Purification

affinity purified.

Conjugation

Non-conjugated

Modification

Unmodified

Isotype

IgG

Product Properties

  • Appearance

    Liquid

  • Formulation

    Supplied in 1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.

  • Concentration

    Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration

  • Storage & Stability

    Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

  • Shipping

    Shipping with blue ice.

Background

  • Function

    DCAF13 is a Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome. Participates in the 18S rRNA processing in growing oocytes, being essential for oocyte nonsurrounded nucleolus (NSN) to surrounded nucleolus (SN) transition |Substrate-recognition component of a DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complex that plays a key role in embryo preimplantation and is required for normal meiotic cycle progression in oocytes. Acts as a maternal factor that regulates oocyte and zygotic chromatin tightness during maternal to zygotic transition. Also involved in the transformation of the endometrium into the decidua, known as decidualization, providing a solid foundation for implantation of blastocysts. Recognizes the histone methyltransferases SUV39H1 and SUV39H2 and directs them to polyubiquitination and proteasomal degradation, which facilitates the H3K9me3 removal and early zygotic gene expression, essential steps for progressive genome reprogramming and the establishment of pluripotency during preimplantation embryonic development. Supports the spindle assembly and chromosome condensation during oocyte meiotic division by targeting the polyubiquitination and degradation of PTEN, a lipid phosphatase that inhibits PI3K pathway as well as oocyte growth and maturation. Targets PMP22 for polyubiquitination and proteasomal degradation[1][2][3][4][5][6].

  • Subcellular Localization

    Nucleus, nucleolus

  • Expression


    Tissue_Specificity: Expressed in the endometrium during decidualization. Expression is down-regulated in preeclampsia decidual tissues

  • Isoforms & Post-Translational Modification

    Q9NV06 has 2 isomers: Q9NV06-1: 51402 Da (predicted); Q9NV06-2: 10919 Da (predicted).

  • Subunit

    Part of the small subunit (SSU) processome, composed of more than 70 proteins and the RNA chaperone small nucleolar RNA (snoRNA) U3 (PubMed:34516797)

  • SwissProt ID

    Q9NV06

  • Gene ID
  • Synonyms

    DCA13_HUMAN antibody; DCAF13 antibody; DDB1 and CUL4 associated factor 13 antibody; DDB1- and CUL4-associated factor 13 antibody; DKFZP564O0463 antibody; GM83 antibody; HSPC064 antibody; MGC126859 antibody; MGC138247 antibody; WD repeat and SOF domain-containing protein 1 antibody; DCA13_HUMAN antibody; DCAF13 antibody; DDB1 and CUL4 associated factor 13 antibody; DDB1- and CUL4-associated factor 13 antibody; DKFZP564O0463 antibody; GM83 antibody; HSPC064 antibody; MGC126859 antibody; MGC138247 antibody; WD repeat and SOF domain-containing protein 1 antibody; WD repeats and SOF1 domain containing antibody; WDSOF1 antibody;

DCAF13 Antibody (YA6537) Related Classifications

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00